NOVNQ — NVN Liquidation Share News
0.000.00%
Last trade - 00:00- $0.02m
- -$4.60m
- $23.68m
U.S. STOCKS ON THE MOVE-Snap, Delta Air Lines, Black Knight, Salesforce
Novan up as FDA to decide on nod for skin infection treatment by Jan '24
Brief: FDA Accepts Novan's NDA For Berdazimer Gel, 10.3% For The Treatment Of Molluscum Contagiosum With PDUFA Goal Date Of January 5, 2024
Novan Inc expected to post a loss of 31 cents a share - Earnings Preview
Novan rises on unit's deal with Japanese firm for skin disease cream
Brief: Epi Health, A Novan Company, Enters Into Exclusive License Agreement With Sato Pharmaceutical For Rhofade® In Japan
Brief: Epi Health, A Novan Company, Executes A $15.0 Million Financing Agreement
Novan Inc reports results for the quarter ended in September - Earnings Summary
Brief: Novan Reports Q3 2022 Financial Results
Novan Inc expected to post a loss of 39 cents a share - Earnings Preview
Novan Inc expected to post a loss of 39 cents a share - Earnings Preview
Novan Inc reports results for the quarter ended in June - Earnings Summary
Brief: Novan reports Q2 results
Novan Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Novan Satisfies $16.5 Million Outstanding Promissory Note
Brief: Novan Reaches Deal With Evening Post Group Regarding Payment, Termination
Brief: Novan Announces Approximately $15 MLn Registered Direct Offering Priced At-The-Market
Novan Inc reports results for the quarter ended in March - Earnings Summary
Brief: Novan Reports Q1 Loss Of 71 Cents Per Share